课题基金 / 基金详情

Targeting Host and Apicomplexan Isoprenoid Pathways

Targeting Host and Apicomplexan Isoprenoid Pathways
靶向宿主和顶复类异戊二烯途径
批准号:
8496713
负责人:
Silvia N Moreno
金额:
$22.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2014-06-30

项目摘要

项目成果

Silvia N Moreno的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Apicomplexa are important pathogens that include the causative agents of malaria, toxoplasmosis, and cryptosporidiosis. Toxoplasma gondii is the causative agent of human toxoplasmosis, a systemic infection acquired mostly through contaminated water and vegetables, or uncooked meat. Tissue cyst formation occurs soon after infection and is responsible for lifelong infection in immunocompetent individuals. At least one-third of the World's population and about 22.5% of Americans are seropositive for toxoplasmosis, making it one of the most prevalent infections in the United States. T. gondii resides intracellularly within parasitophorous vacuoles, and reactivation and dissemination of infection to different organs may occur following immune suppression. Cryptosporidium parvum is responsible for significant disease burden among children in developing countries and it can result in chronic and life-threatening enteritis in AIDS patients. The present chemotherapy available against T. gondii chronic infection and cryptosporidiosis is not effective and new drugs are urgently needed to treat both infections. T. gondii lacks a mevalonate pathway for the synthesis of isoprenoid precursors but harbor a 1-deoxy-D- xylulose-5-phosphate (DOXP) pathway in its apicoplast. This pathway generates isopentenyl diphosphate (IPP) and dimethyallyl diphosphate (DMAPP), which are condensed by the action of a unique farnesyl diphosphate synthase (TgFPPS) into farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP). Our preliminary data have indicated that the DOXP pathway is essential for T. gondii survival in its host. Surprisingly, though, drugs acting on the mevalonate pathway, like statins, are active in vitro and in vivo against the parasite. These results indicate that the parasite needs to synthesize some isoprenoid precursors (IPP, DMAPP), while salvaging others (FPP, GGPP) from its host. We will exploit this to develop a double hit strategy. Remarkably the model suggests that Cryptosporidium parvum should be highly susceptible to this approach.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ejmech.2012.12.015
发表时间: 2013-02
期刊: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
影响因子: 6.7
作者: [Recher, Marion, Barboza, Alejandro P., Li, Zhu-Hong, Galizzi, Melina, Ferrer-Casal, Mariana, Szajnman, Sergio H., Docampo, Roberto, Moreno, Silvia N. J., Rodriguez, Juan B.]
通讯作者: Rodriguez, Juan B.
The calcium signaling toolkit of the Apicomplexan parasites Toxoplasma gondii and Plasmodium spp.
Apicomplexan寄生虫的钙信号传导工具包弓形虫和疟原虫属。
DOI: 10.1016/j.ceca.2014.12.010
发表时间: 2015-03
期刊: Cell calcium
影响因子: 4
作者: [Lourido S, Moreno SN]
通讯作者: Moreno SN
Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.
作为抗寄生虫剂的 WC-9 类似物的设计、合成和生物学评价。
DOI: 10.1016/j.ejmech.2013.09.009
发表时间: 2013
期刊: European journal of medicinal chemistry
影响因子: 6.7
作者: [Elicio,PabloD, Chao,MaríaN, Galizzi,Melina, Li,Catherine, Szajnman,SergioH, Docampo,Roberto, Moreno,SilviaNJ, Rodriguez,JuanB]
通讯作者: Rodriguez,JuanB
Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii.
WC-9 的含氟类似物和结构相关类似物对抗两种细胞内寄生虫:克氏锥虫和弓形虫的活性。
DOI: 10.1002/cmdc.201600505
发表时间: 2016
期刊: ChemMedChem
影响因子: 3.4
作者: [Chao,MaríaN, Li,Catherine, Storey,Melissa, Falcone,BrunoN, Szajnman,SergioH, Bonesi,SergioM, Docampo,Roberto, Moreno,SilviaNJ, Rodriguez,JuanB]
通讯作者: Rodriguez,JuanB
The role of polyphosphate in Toxoplasma gondii
  • 批准号:
    10681078
  • 项目类别:
  • 资助金额:
    $21.28万
  • 财政年份:
    2023
  • 负责人:
    Silvia N Moreno
  • 依托单位:
Divergent Calcium Channels of the Apicomplexan parasite Toxoplasma gondii
  • 批准号:
    10681807
  • 项目类别:
  • 资助金额:
    $62.48万
  • 财政年份:
    2023
  • 负责人:
    Silvia N Moreno
  • 依托单位:
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
  • 批准号:
    10608408
  • 项目类别:
  • 资助金额:
    $41.57万
  • 财政年份:
    2022
  • 负责人:
    Silvia N Moreno
  • 依托单位:
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
  • 批准号:
    10707505
  • 项目类别:
  • 资助金额:
    $43.11万
  • 财政年份:
    2022
  • 负责人:
    Silvia N Moreno
  • 依托单位:
海外基金